(Reuters) -U.S. President Donald Trump signed an executive order aimed at ensuring a "resilient" supply chain for essential medicines in the U.S. by filling the Strategic Active Pharmaceutical Ingredients Reserve with critical drug components, the White House said on Wednesday.
(Reporting by Bhargav Acharya; Editing by Jasper Ward)